AKL Therapeutics

AKL Therapeutics is a pharmaceutical company that is transforming the way drugs are developed by drawing inspiration from nature to address some of the biggest challenges facing modern medicine today. AKL Therapeutics is committed to transforming patients' lives through pioneering innovation. We first identify plant-derived secondary metabolites whose efficacy and safety have been proven, then synthesize these metabolites before proceeding with standard pharmaceutical clinical development. This innovative approach significantly increases the chances of success while reducing the risk of side effects. Formal human clinical trials are currently underway to evaluate the safety and efficacy of the investigational oral therapy "APPA" for the treatment of osteoarthritis, a common degenerative disease with limited treatment options and no cure. APPA is also being evaluated in other inflammatory diseases, and other molecules are under investigation.